Gentamicin sulfate
Gentamicin sulfate: 3 brands, 57 generics; first approved Feb 18, 1982; generic available.
Generic available: 57 ANDA applications approved.
Brand (NDA) products
- GARAMYCINRLDSCHERINGNDA 050505-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2MG BASE/ML INJECTABLE INTRATHECAL Discontinued - - GARAMYCINRLDSCHERINGNDA 050039-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Discontinued - - SCHERINGNDA 050425-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE OINTMENT OPHTHALMIC Discontinued -
Generic (ANDA) products (57)
- GENTAMICIN SULFATEEUGIA PHARMAANDA 2152362024
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEEUGIA PHARMAANDA 2152372024
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Rx AP - GENTAMICIN SULFATEENCUBEANDA 2092332018
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Discontinued - - GENTAMICIN SULFATERSFERA PHARMS LLCANDA 0650242004
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE OINTMENT OPHTHALMIC Rx - - GENTAMICIN SULFATEPADAGIS USANDA 0651212004
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Discontinued - - PHARMOBEDIENTANDA 0641632001
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Discontinued - - GENTAMICIN SULFATESCIEGEN PHARMSANDA 0640931995
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE OINTMENT OPHTHALMIC Discontinued - - GENTAMICIN SULFATEBAUSCH AND LOMB INCANDA 0640481994
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Rx AT - GENTAMICIN SULFATECOSETTE PHARMS NCANDA 0640561994
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE CREAM TOPICAL Rx AT - GENTAMICIN SULFATECOSETTE PHARMS NCANDA 0640541994
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Rx AT - GENTAMICIN SULFATETEVA PARENTERALANDA 0631491991
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATETEVA PARENTERALANDA 0631061991
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEPACOANDA 0629321988
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 3MG BASE/ML SOLUTION/DROPS OPHTHALMIC Discontinued - - B BRAUNANDA 062814198714 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.8MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.2MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.4MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.6MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.8MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 2MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 2.4MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 40MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 60MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 70MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 80MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 90MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 100MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 120MG BASE/100ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEEPIC PHARMA LLCANDA 0626351987
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Discontinued - - GENTAMICIN SULFATEHOSPIRAANDA 0626121986
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATERSFRESENIUS KABI USAANDA 06236619862 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Rx AP EQ 10MG BASE/ML INJECTABLE INJECTION Rx AP - HOSPIRAANDA 062588198610 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 1.2MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.4MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.6MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.8MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 2MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 60MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 70MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 80MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 90MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 100MG BASE/100ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEALCON PHARMS LTDANDA 0625231985
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Discontinued - - PHARMAFAIRANDA 0624931985
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATESOLOPAKANDA 06250719852 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEPHARMADERMANDA 0625341984
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Discontinued - - ALLERGANANDA 0624521984
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Discontinued - - GENTAMICIN SULFATEFOUGERA PHARMS INCANDA 0625331984
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Rx AT - NOVARTISANDA 0625011984
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE OINTMENT OPHTHALMIC Discontinued - - GENTAMICIN SULFATEFOUGERA PHARMS INCANDA 0625311984
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE CREAM TOPICAL Discontinued - - GENTAMICIN SULFATEPHARMADERMANDA 0625301984
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 1MG BASE/GM CREAM TOPICAL Discontinued - - NOVARTISANDA 0624801984
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Discontinued - - GENTAMICIN SULFATEALPHARMA US PHARMSANDA 0624961984
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Discontinued - - GENTAMICIN SULFATESUN PHARMA CANADAANDA 0624771983
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Discontinued - - GENTAMICIN SULFATEALPHARMA US PHARMSANDA 0624711983
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE CREAM TOPICAL Discontinued - - PHARMAFAIRANDA 0624581983
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE CREAM TOPICAL Discontinued - - GENTAMICIN SULFATEHOSPIRAANDA 06242019832 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Rx AP EQ 40MG BASE/ML INJECTABLE INJECTION Rx AP - HOSPIRAANDA 062414198310 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 1.2MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.4MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.6MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.8MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 2MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 60MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 70MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 80MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 90MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 100MG BASE/100ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEABBOTTANDA 062413198310 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 1.2MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.4MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.6MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1.8MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 2MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 60MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 70MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 80MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 90MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 100MG BASE/100ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATESUN PHARMA CANADAANDA 0624271983
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE CREAM TOPICAL Discontinued - - PHARMAFAIRANDA 0624431983
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 3MG BASE/GM OINTMENT OPHTHALMIC Discontinued - - PHARMAFAIRANDA 0624441983
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Discontinued - - PHARMAFAIRANDA 0624401983
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Discontinued - - GENTAMICIN SULFATEPHARM SPECANDA 0623401983
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - BAXTER HLTHCAREANDA 062373198210 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.8MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 80MG BASE/100ML INJECTABLE INJECTION Rx - EQ 40MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 60MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 100MG BASE/100ML INJECTABLE INJECTION Rx - EQ 120MG BASE/100ML INJECTABLE INJECTION Rx - EQ 1.2MG BASE/ML INJECTABLE INJECTION Rx - EQ 1.6MG BASE/ML INJECTABLE INJECTION Rx - EQ 2MG BASE/ML INJECTABLE INJECTION Rx - EQ 2.4MG BASE/ML INJECTABLE INJECTION Discontinued - - INTL MEDICATIONANDA 06232519823 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 100MG BASE/100ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEKALAPHARMANDA 0623541982
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEFRESENIUS KABI USAANDA 06235619822 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATERSPADAGIS USANDA 0623511982
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Rx AT - SCHERINGANDA 060462-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE CREAM TOPICAL Discontinued - - GENTAMICIN SULFATERSPADAGIS USANDA 062307-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE CREAM TOPICAL Rx AT - KING PHARMSANDA 062289-2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - BRISTOLANDA 062288-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - SCHERINGANDA 061716-2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 1MG BASE/ML INJECTABLE INJECTION Discontinued - - SCHERINGANDA 061739-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEHIKMAANDA 062251-2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Rx AP EQ 10MG BASE/ML INJECTABLE INJECTION Rx AP - GENTAMICIN SULFATEWATSON LABSANDA 062318-2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - - GENTAMICIN SULFATEWYETH AYERSTANDA 062264-2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - PHARMACIA AND UPJOHNANDA 062248-2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 40MG BASE/ML INJECTABLE INJECTION Discontinued - - SCHERINGANDA 060463-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.1% BASE OINTMENT TOPICAL Discontinued - - GENTAMICIN SULFATERSSANDOZANDA 062196-
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 0.3% BASE SOLUTION/DROPS OPHTHALMIC Rx AT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Approval history
Approvals span 1982โ2024 across 60 FDA applications.
Gentamicin sulfate: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Gentamicin sulfate
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo
